Show the full website


ALK launches tablet vaccine for tree pollen allergy

The allergy solutions company ALK launches its tablet vaccine for tree pollen allergy in Canada, where more than seven million people suffer from tree pollen allergy. The launch completes ALK's tablet portfolio in Canada, where the expected sales potential is in the high figures.

Foto: ALK / PR

Barely half-a-year after the Canadian health authorities approved the allergy company ALK's tablet vaccine for tree pollen allergy, the first vaccines are now available on the market in Canada.

The treatment, which is being marketed under the name Itulazax in Europe, is sold as Itulatek in Canada, and it works against birch pollen, hazel pollen and elm pollen.

Read this article for free

Register with your E-mail.
No credit card required.

Get full access for you and your coworkers.

Start a free company trial today

Receive newsletter from MedWatch today

NB: Subscribing to the newsletter is free.

More from MedWatch


See all jobs